Adaptimmune Therapeutics Stock Forecast - Daily Balance Of Power
| ADAP Stock | USD 1.24 0.09 7.83% |
Adaptimmune Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Adaptimmune Therapeutics stock prices and determine the direction of Adaptimmune Therapeutics Plc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Adaptimmune Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Adaptimmune Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Adaptimmune Therapeutics' systematic risk associated with finding meaningful patterns of Adaptimmune Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Adaptimmune Therapeutics to cross-verify your projections. Adaptimmune |
Open Interest Against 2024-05-17 Adaptimmune Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Adaptimmune Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Adaptimmune Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Adaptimmune Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Adaptimmune Therapeutics' open interest, investors have to compare it to Adaptimmune Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Adaptimmune Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Adaptimmune. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Adaptimmune Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Adaptimmune Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Adaptimmune Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Balance of Power indicator (or BOP) measures the strength of Adaptimmune Therapeutics Plc market sensitivity to bulls and bears. It estimates the ability of Adaptimmune Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Adaptimmune Therapeutics Balance of Power indicator one can determine a trend of the price direction.| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.3571 | 9.2 T |
| Check Adaptimmune Therapeutics Volatility | Backtest Adaptimmune Therapeutics | Information Ratio |
Adaptimmune Therapeutics Trading Date Momentum
| On May 16 2024 Adaptimmune Therapeutics Plc was traded for 1.24 at the closing time. The top price for the day was 1.24 and the lowest listed price was 1.24 . There was no trading activity during the period 0.0. Lack of trading volume on May 16, 2024 did not affect price variability. The overall trading delta against the current closing price is 7.26% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Adaptimmune Therapeutics to competition |
Other Forecasting Options for Adaptimmune Therapeutics
For every potential investor in Adaptimmune, whether a beginner or expert, Adaptimmune Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Adaptimmune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Adaptimmune. Basic forecasting techniques help filter out the noise by identifying Adaptimmune Therapeutics' price trends.View Adaptimmune Therapeutics Related Equities
| Risk & Return | Correlation |
Adaptimmune Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Adaptimmune Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Adaptimmune Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Adaptimmune Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Adaptimmune Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adaptimmune Therapeutics shares will generate the highest return on investment. By undertsting and applying Adaptimmune Therapeutics stock market strength indicators, traders can identify Adaptimmune Therapeutics Plc entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.08 | |||
| Day Median Price | 1.24 | |||
| Day Typical Price | 1.24 | |||
| Price Action Indicator | 0.045 | |||
| Period Momentum Indicator | 0.09 | |||
| Relative Strength Index | 48.88 |
Adaptimmune Therapeutics Risk Indicators
The analysis of Adaptimmune Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Adaptimmune Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adaptimmune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.5 | |||
| Semi Deviation | 5.07 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.5 | |||
| Downside Variance | 29.74 | |||
| Semi Variance | 25.67 | |||
| Expected Short fall | (5.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Adaptimmune Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adaptimmune Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Adaptimmune Stock
| 0.75 | VRDN | Viridian Therapeutics | PairCorr |
| 0.68 | FBIO | Fortress Biotech Financial Report 20th of May 2024 | PairCorr |
| 0.71 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
Moving against Adaptimmune Stock
| 0.72 | ACB | Aurora Cannabis Financial Report 12th of June 2024 | PairCorr |
| 0.54 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.42 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Adaptimmune Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adaptimmune Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adaptimmune Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adaptimmune Therapeutics Plc to buy it.
The correlation of Adaptimmune Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adaptimmune Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adaptimmune Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adaptimmune Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Adaptimmune Therapeutics to cross-verify your projections. Note that the Adaptimmune Therapeutics information on this page should be used as a complementary analysis to other Adaptimmune Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Adaptimmune Stock analysis
When running Adaptimmune Therapeutics' price analysis, check to measure Adaptimmune Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptimmune Therapeutics is operating at the current time. Most of Adaptimmune Therapeutics' value examination focuses on studying past and present price action to predict the probability of Adaptimmune Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptimmune Therapeutics' price. Additionally, you may evaluate how the addition of Adaptimmune Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Adaptimmune Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptimmune Therapeutics. If investors know Adaptimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptimmune Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 0.3 | Quarterly Revenue Growth (0.98) | Return On Assets (0.28) | Return On Equity (1.88) |
The market value of Adaptimmune Therapeutics is measured differently than its book value, which is the value of Adaptimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptimmune Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Adaptimmune Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptimmune Therapeutics' market value can be influenced by many factors that don't directly affect Adaptimmune Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptimmune Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptimmune Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptimmune Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.